These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Intravenous immunoglobulin therapy for the treatment of severe atopic dermatitis. Lamb SR; Rademaker M Expert Opin Pharmacother; 2001 Jan; 2(1):67-74. PubMed ID: 11336569 [TBL] [Abstract][Full Text] [Related]
10. The influence of interferon-gamma and interleukin-4 on IgE production in B lymphocytes of patients with atopic dermatitis. A possible criterion for selection of patients for interferon therapy. Gruner S; Liebenthal C; Heusser C; Brinkmann V; Zwirner A; Reinicke C; Harnack K; Sönnichsen N; Volk HD Acta Derm Venereol; 1991; 71(6):484-7. PubMed ID: 1685830 [TBL] [Abstract][Full Text] [Related]
11. Combined therapy with low-dose omalizumab and intravenous immunoglobulin for severe atopic dermatitis. Report of four cases. Toledo F; Silvestre JF; Muñoz C J Eur Acad Dermatol Venereol; 2012 Oct; 26(10):1325-7. PubMed ID: 22050044 [No Abstract] [Full Text] [Related]
12. Dupilumab utility in difficult-to-treat asthma. M Walsh G Immunotherapy; 2019 Mar; 11(4):261-264. PubMed ID: 30678554 [No Abstract] [Full Text] [Related]
14. A randomized controlled evaluator-blinded trial of intravenous immunoglobulin in adults with severe atopic dermatitis. Paul C; Lahfa M; Bachelez H; Chevret S; Dubertret L Br J Dermatol; 2002 Sep; 147(3):518-22. PubMed ID: 12207594 [TBL] [Abstract][Full Text] [Related]
15. Changes of serum levels of interleukin-2, intercellular adhesion molecule-1, endothelial leukocyte adhesion molecule-1 and Th1 and Th2 cell in severe atopic dermatitis after intravenous immunoglobulin therapy. Huang JL; Lee WY; Chen LC; Kuo ML; Hsieh KH Ann Allergy Asthma Immunol; 2000 Mar; 84(3):345-52. PubMed ID: 10752921 [TBL] [Abstract][Full Text] [Related]
16. The treatment of atopic dermatitis with adjunctive high-dose intravenous immunoglobulin: a report of three patients and review of the literature. Jolles S; Hughes J; Rustin M Br J Dermatol; 2000 Mar; 142(3):551-4. PubMed ID: 10735971 [TBL] [Abstract][Full Text] [Related]
17. T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis. Akdis CA; Akdis M; Simon D; Dibbert B; Weber M; Gratzl S; Kreyden O; Disch R; Wüthrich B; Blaser K; Simon HU J Invest Dermatol; 1999 Oct; 113(4):628-34. PubMed ID: 10504452 [TBL] [Abstract][Full Text] [Related]
18. Clinical approach to the patient with refractory atopic dermatitis. Izadi N; Leung DYM Ann Allergy Asthma Immunol; 2018 Jan; 120(1):23-33.e1. PubMed ID: 29273125 [No Abstract] [Full Text] [Related]
19. Experience with intravenous immunoglobulin in severe childhood atopic dermatitis. Ozen A; Baris S; Karakoc Aydiner E; Yucelten D; Nadir Bahceciler N Allergol Immunopathol (Madr); 2012; 40(2):131-3. PubMed ID: 21855202 [No Abstract] [Full Text] [Related]
20. Black currant seed oil supplementation of mothers enhances IFN-γ and suppresses IL-4 production in breast milk. Linnamaa P; Nieminen K; Koulu L; Tuomasjukka S; Kallio H; Yang B; Tahvonen R; Savolainen J Pediatr Allergy Immunol; 2013 Sep; 24(6):562-6. PubMed ID: 23980846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]